The stock of Tivic Health Systems Inc. (NASDAQ:TIVC) last traded at $0.04, up 6.42% from the previous session.
TIVC stock price is now -48.89% away from the 50-day moving average and -91.46% away from the 200-day moving average. The market capitalization of the company currently stands at $4.95M.
A total of 11.47% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in TIVC stock. A new stake in Tivic Health Systems Inc. shares was purchased by TWO SIGMA SECURITIES, LLC during the first quarter worth $4,000. MILLENNIUM MANAGEMENT LLC invested $1,000 in shares of TIVC during the first quarter. In the first quarter, CUBIST SYSTEMATIC STRATEGIES, LLC acquired a new stake in Tivic Health Systems Inc. valued at approximately $1,000. In total, there are 16 active investors with 0.20% ownership of the company’s stock.
With an opening price of $0.0370 on Monday morning, Tivic Health Systems Inc. (NASDAQ: TIVC) set off the trading day. During the past 12 months, Tivic Health Systems Inc. has had a low of $0.04 and a high of $2.34. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 4.10, and a quick ratio of 3.50. The fifty day moving average price for TIVC is $0.0766 and a two-hundred day moving average price translates $0.4572 for the stock.
The latest earnings results from Tivic Health Systems Inc. (NASDAQ: TIVC) was released for Mar, 2023. According to the Medical Devices Company, earnings per share came in at -$0.11, inline with analysts’ expectations of -$0.11. This compares to -$0.23 EPS in the same period last year. The company reported revenue of $0.38 million for the quarter, compared to $0.43 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -12.15 percent. For the current quarter, analysts expect TIVC to generate $630k in revenue.
Tivic Health Systems Inc.(TIVC) Company Profile
Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
